· Published by Health Canada · Official notice
| Brand | Lot | Product Name | Market Authorization | Dosage Form | Strength |
|---|---|---|---|---|---|
| ACH-SITAGLIPTIN | P2206575, P2206981 | ACH-SITAGLIPTIN | DIN 02512491 | Tablet | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MG |
| ACH-SITAGLIPTIN | P2206573 | ACH-SITAGLIPTIN | DIN 02512475 | Tablet | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MG |
| ACH-SITAGLIPTIN | P2206574 | ACH-SITAGLIPTIN | DIN 02512483 | Tablet | SITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG |
The affected lots may exceed the established acceptable intake limit for 7-nitroso-3-(trifluoromethyl)- 5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine (NTTP).